Login / Signup

Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention.

Mohamed Mahmoud DoghaHossam ShakerAssem AbdelazeezAhmed Abd-El LatifMahmoud S ElAdawy
Published in: World journal of urology (2024)
Double-dose 0.8mg tamsulosin as an alpha-blocker therapy appears to be a viable temporary management option for BPH patients who have not responded to the standard single dose 0.4mg tamsulosin and are not suitable candidates for TUR intervention.
Keyphrases